Anti-atopic dermatitis effects of Poncirus trifoliata Rafinesque via regulation of immune response and nerve growth factor

Article information

J Korean Med. 2016;37(1):10-20
Publication date (electronic) : 2016 March 31
doi : https://doi.org/10.13048/jkm.16002
Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University
Correspondence to: 양웅모(Woong Mo Yang), 서울시 동대문구 회기동 1번지 경희대학교 한의과대학, Tel: +82-2-961-2209, E-mail: wmyang@khu.ac.kr
Received 2015 November 25; Revised 2016 March 14; Accepted 2016 March 17.

Abstract

Objectives:

Poncirus trifoliata Rafinesque has been known to have anti-allergic effects in skin diseases. However, anti-atopic dermatitis effects of P. trifoliata Rafinesque have not been studied yet in skin diseases. The present study evaluated the anti-atopic dermatitis effects of P. trifoliata Rafinesque (PTR) using external treatments on AD.

Methods:

AD lesions were induced by the repeated application of 2, 4-Dinitrochlorobenzene (DNCB) on the shaved back of BALB/c mice. 100 μℓ of PTR extracts was applied to the AD lesions for 11 days. Histological assessments, mast cells count and serum levels of IgE were analyzed. The anti-pruritic effects of PTR were examined by the change of scratching frequency and nerve growth factor (NGF) expression. In addition, the anti-inflammatory effects of PTR were examined by the expressions of Th2/Th1 cytokines and pro-inflammatory in dorsal skin.

Results:

Histopathological findings showed that topical application of PTR decreased the thickness of dermal and epidermal skin compared with the DNCB group. PTR also notably decreased the mast cells count and serum IgE. The scratching behavior of mice and expression of NGF were significantly reduced. In addition, PTR group significantly suppressed the IL-4, IL-6, IFN-γ and TNF-α cytokines compared to the DNCB group.

Conclusions:

These results indicated that P. trifoliata Rafinesque possess anti-pruritus and anti-atopic dermatitis properties. Therefore, P. trifoliata Rafinesque might be used for treatment of pruritus and atopic dermatitis.

Fig. 1.

Experimental scheme for atopic dermatitis induction and PTR application.

Fig. 2.

Effects of PTR on skin thickness in DNCB-induced mice. (A) The thickness of epidermis, (B) the thickness of dermis. Hematoxylin-eosin staining showed a decrease thickness of epidermis and dermis in the PTR-treated group. Results shown are representative of five observations. Data are presented as means ± SD and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001, versus the DNCB group. Magnification: X 100.

Fig. 3.

Effects of PTR on the number of mast cells in DNCB-induced mice. Toluidine blue staining showed a decrease the number of mast cells in the RTR group. Results shown are representative of five observations. Data are presented as means ± SD and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001, ** P < 0.01 versus the DNCB group. Magnification: X 100.

Fig. 4.

Effects of PTR on serum IgE level in DNCB-induced mice. Data are presented as means ± SD and analyzed with ANOVA ### P < 0.001, versus the NOR group. *** P < 0.001, versus the DNCB group.

Fig. 5.

Effects of PTR on scratching behavior in DNCB-induced mice. Scratching behavior of mouse was checked after 1 h had passed following the last application of DNCB (on 18 day). Each mouse of all group were videotaped for 20 min to count the number of scratching behavior. Data are presented as means ± SD (n = 5) and analyzed with ANOVA. ### P < 0.001, versus the NOR group. * P < 0.05, versus the DNCB group. N.S: non-significant.

Fig. 6.

Effects of PTR on NGF expression in DNCB-induced mice. The expression of NGF was confirmed by western blotting assay. ### P < 0.001, versus the NOR group. ## P < 0.01, versus the DNCB group. N.S: non-significant.

Fig. 7.

Effects of PTR on levels of cytokine in DNCB-induced mice. The cytokine levels of IL-4, −6, IFN-γ and TNF-α were measured in the dorsal skin using mouse ELISA kits. Data are presented as means ± SD (n = 5) and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001 * P < 0.05, versus the DNCB group.

References

1. Min DL, Park EJ, Kang KH. Review of Clinical and Experimental Studies on External Application Treatment for Atopic Dermatitis in the Korean Literature. J Korean Orient Pediatr 2013;27(1):36–49.
2. Park Y. Status of clinical practice on diagnosis and management of atopic dermatitis in Korea: a questionnaire survey of physicians. Allergy Asthma Respir Dis 2013;1(3):257–265.
3. Lee YJ, Kang HY, Jeong BJ, Kim KE, Lee KY, Lee SY. Significance of atopic index in children with atopic dermatitis. Allergy Asthma Respir Dis 1994;4(2):11–24.
4. Choi HJ, Sim BY, Miyamoto T. Effects of Lobophytum crassum extract (MC-1) on Various Immunological Factors Related to Pathogenesis of Atopic Dermatitis in Dermatophagoides Pteronyssinus Treated NC/Nga mice. Korea J Herbol 2015;30(1):95–101.
5. Yun HJ, Ko WS. Clinical Study of Atopic Dermatitis; the Classification of Oriental Medical Clinical type and Treatment. J Korean Oriental Med 2001;22(2):10–21.
6. Lee SH, Yun YG. Study for Treatment of Atopic Dermatitis in Oriental Medical Prescription. J Korean Med 2006;15(1):56–69.
7. Shin SH, Kim MB, Byun SM, Lee HS, Park SG, Ko WS, et al. A Review on External Treatment for Atopic Dermatitis in Korean Journals. J Korean Orient Med Ophthalmol Otolaryngol Dermato 2008;21(2):80–93.
8. Katayama I, Kohno Y, Akiyama K, Ikezawa Z, Kondo N, Tamaki K, et al. Japanese Society of Allergology. Japanese Guideline for Atopic Dermatitis. Allergol Int 2011;60:205–220.
9. Boneberger S, Rupec RA, Ruzicka T. Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversies. Clin Dermatol 2010;28(1):57–61.
10. Cha KB, Kim YS, Seol IC. Literatual study on Atopic dermatitis. Daejeon J Institute Orient Med 2005;14(2):113–126.
11. Kim EH, Lee BW, Kim EH. A Literal Study of the Main Symptoms of Atopic Dermatitis. J Korean Med Classic 2009;22(1):207–228.
12. College of korean medicine co association editorial board. Textbook of herbology Seoul: Younglimsa; 2011. p. 392.
13. Aeom YD, Kim DH, Jeong JG, Shin MK, Song HJ. The Comparative Study of Fructus Immaturus Ponciri and Fructus Ponciri Effect on Allergic Re action. J Korean Orient Med 2001;22(4):10–21.
14. Kang BS. Korean medicine clinical allergy Seoul: Seongbosa; 1988. p. 57–59.
15. Hwang KH, Lee EJ, Song BK, Kim HK. Mechanism of Inhibitory Action of Anaphylaxis by Aqueous Extract of Poncirus trifoliata. J Korean Orient Med 1997;18(1):316–325.
16. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352(22):2314–2324.
17. Cho JB, Lee JH, Suh JM, Yu JS, Lee HS, Park EA, et al. Change in Quality of Life according to the Change in Atopic Dermatitis Severity. Allergy Asthma Respir Dis 2012;22(1):86–99.
18. Carstens E, Akiyama T. Itch: Mechanisms and Treatment Boca Raton (FL): CRC Press/Taylor & francis; 2014. Ebook-Chapter 3.
19. Lee YJ, Kang HY, Jeng BJ, Kim GE, Lee GY, Lee SY. Significance of atopic index in children with atopic dermatitis. Allergy Asthma Respir Dis 1994;4(2):11–24.
20. Leung DY, Bieber T. Atopic dermatitis. Lancet Diabetes Endocrinol 2003;361:151–160.
21. Hong SJ. Review Articles: Mast Cells and Allergic Diseases. Allergy Asthma Respir Dis 2000;10(3):207–217.
22. Hwang SY, Lee SH, Lee CW, Kim JH, Jang SI, Kim AN, et al. Anti-inflammatory and Anti-Pruritonic Effects of WSY-1075 composited with Medicinal Plants on the Activated Rat Peritoneal Mast cells and Mouse Pruritus. Korea J Herbol 2013;28(4):93–100.
23. Metz M, Grundmann S, Ständer S. Pruritus: an overview of current concepts. Vet Dermatol 2011;22(2):121–131.
24. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009;53(1):48–54.
25. Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 2000;22(2):71–79.
26. Lim JH, Kang H, Park YM, Cho SH, Lee SY. Effect of substance P on Production of interleukin-12 and interferon-gamma from peripheral blood mononuclear cells of chronic severe atopic dermatitis patients. J Asthma 2001;21(4):636–646.
27. Lee IJ. Epidermal cytokine profiles in allergic and irritant contact dermatitis. Yonsei Univ Grad School, Doctoral dissertation. 2002. 28.
28. Yu JS, Kim JU, Lee CH, Lee SR, Yook TH. The Effects of Lonicerae Flos, Forsythiae Fluctus and Hwangryunhaedok Decoction Pharmacopuncture on Atopic Dermatitis in NC/Nga Mice. J Korean Acupunct Moxibust Soc 2015;32(4):119–131.
29. Yu HS, Gim S, Song H, Ji J, Bal JW, Kim D. A Study on the Immune Modulation of Chunghwatang (CHT) in Atopic Dermatitis Animal Models. Daejeon J Institute Orient Med 2012;21(1):53–64.

Article information Continued

Fig. 1.

Experimental scheme for atopic dermatitis induction and PTR application.

Fig. 2.

Effects of PTR on skin thickness in DNCB-induced mice. (A) The thickness of epidermis, (B) the thickness of dermis. Hematoxylin-eosin staining showed a decrease thickness of epidermis and dermis in the PTR-treated group. Results shown are representative of five observations. Data are presented as means ± SD and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001, versus the DNCB group. Magnification: X 100.

Fig. 3.

Effects of PTR on the number of mast cells in DNCB-induced mice. Toluidine blue staining showed a decrease the number of mast cells in the RTR group. Results shown are representative of five observations. Data are presented as means ± SD and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001, ** P < 0.01 versus the DNCB group. Magnification: X 100.

Fig. 4.

Effects of PTR on serum IgE level in DNCB-induced mice. Data are presented as means ± SD and analyzed with ANOVA ### P < 0.001, versus the NOR group. *** P < 0.001, versus the DNCB group.

Fig. 5.

Effects of PTR on scratching behavior in DNCB-induced mice. Scratching behavior of mouse was checked after 1 h had passed following the last application of DNCB (on 18 day). Each mouse of all group were videotaped for 20 min to count the number of scratching behavior. Data are presented as means ± SD (n = 5) and analyzed with ANOVA. ### P < 0.001, versus the NOR group. * P < 0.05, versus the DNCB group. N.S: non-significant.

Fig. 6.

Effects of PTR on NGF expression in DNCB-induced mice. The expression of NGF was confirmed by western blotting assay. ### P < 0.001, versus the NOR group. ## P < 0.01, versus the DNCB group. N.S: non-significant.

Fig. 7.

Effects of PTR on levels of cytokine in DNCB-induced mice. The cytokine levels of IL-4, −6, IFN-γ and TNF-α were measured in the dorsal skin using mouse ELISA kits. Data are presented as means ± SD (n = 5) and analyzed with ANOVA. ### P < 0.001, versus the NOR group. *** P < 0.001 * P < 0.05, versus the DNCB group.